15 September 2020 : Case report
Ineffective Subtilisin/Kexin Type 9 (PCSK9) Inhibitors Monotherapy in Dyslipidemia with Low-Density Lipoprotein Cholesterol (LDL-C) Receptor Abnormalities: A Report of 2 Cases
Unusual or unexpected effect of treatment
DOI: 10.12659/AJCR.923722
Am J Case Rep 2020; 21:e923722